清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

伦瓦提尼 肝细胞癌 FGF19型 内科学 医学 肿瘤科 肝细胞癌 生物标志物 癌症研究 生物 成纤维细胞生长因子 索拉非尼 受体 遗传学
作者
Yuta Myojin,Takahiro Kodama,Kazuki Maesaka,Daisuke Motooka,Yu Sato,Satoshi Tanaka,Yuichi Abe,Kazuyoshi Ohkawa,Eiji Mita,Yoshito Hayashi,Hayato Hikita,Ryotaro Sakamori,Tomohide Tatsumi,Ayumu Taguchi,Hidetoshi Eguchi,Tetsuo Takehara
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:27 (4): 1150-1161 被引量:59
标识
DOI:10.1158/1078-0432.ccr-20-3382
摘要

Abstract Purpose: Hepatocellular carcinoma (HCC) is characterized by high intertumor heterogeneity of genetic drivers. Two multitarget tyrosine kinase inhibitors (TKI), lenvatinib and sorafenib, are used as standard-of-care chemotherapeutics in patients with advanced HCC, but a stratification strategy has not been established because of a lack of efficacious biomarkers. Therefore, we sought biomarkers that indicate lenvatinib-susceptible HCC. Experimental Design: We performed genetic screening of HCC driver genes involved in TKI susceptibility using a novel HCC mouse model in which tumor diversity of genetic drivers was recapitulated. A biomarker candidate was evaluated in human HCC cell lines. Secreted proteins from HCC cells were then screened using mass spectrometry. Serum and tumor levels of the biomarker candidates were analyzed for their association and prediction of overall survival in patients with HCC. Results: We found that lenvatinib selectively eliminated FGF19-expressing tumors, whereas sorafenib eliminated MET- and NRAS-expressing tumors. FGF19 levels and lenvatinib susceptibility were correlated in HCC cell lines, and FGF19 inhibition eliminated lenvatinib susceptibility. Lenvatinib-resistant HCC cell lines, generated by long-term exposure to lenvatinib, showed FGF19 downregulation but were resensitized to lenvatinib by FGF19 reexpression. Thus, FGF19 is a tumor biomarker of lenvatinib-susceptible HCC. Proteome and secretome analyses identified ST6GAL1 as a tumor-derived secreted protein positively regulated by FGF19 in HCC cells. Serum ST6GAL1 levels were positively correlated with tumor FGF19 expression in patients with surgically resected HCC. Among patients with serum ST6GAL1-high HCC who underwent TKI therapy, lenvatinib therapy showed significantly better survival than sorafenib. Conclusions: Serum ST6GAL may be a novel biomarker that identifies lenvatinib-susceptible FGF19-driven HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
luckygirl完成签到 ,获得积分10
2秒前
独孤完成签到 ,获得积分10
3秒前
xue112完成签到 ,获得积分10
16秒前
20秒前
25秒前
zhdjj完成签到 ,获得积分10
27秒前
蓝胖子完成签到 ,获得积分10
31秒前
41秒前
45秒前
小蜜蜂发布了新的文献求助10
48秒前
领导范儿应助djbj2022采纳,获得10
48秒前
1分钟前
小蜜蜂完成签到,获得积分20
1分钟前
1分钟前
1分钟前
chichenglin完成签到 ,获得积分0
1分钟前
nano完成签到 ,获得积分10
1分钟前
sa完成签到 ,获得积分10
1分钟前
珊珊4532完成签到 ,获得积分10
1分钟前
桐桐应助ZIS采纳,获得10
1分钟前
Yina完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
和谐的冬莲完成签到 ,获得积分10
2分钟前
2分钟前
ZIS发布了新的文献求助10
2分钟前
孤独听雨的猫完成签到 ,获得积分10
2分钟前
harden9159完成签到,获得积分10
2分钟前
ys1008完成签到,获得积分10
2分钟前
文献蚂蚁完成签到,获得积分10
2分钟前
美满惜寒完成签到,获得积分10
2分钟前
真的OK完成签到,获得积分10
2分钟前
啪嗒大白球完成签到,获得积分10
2分钟前
洋芋饭饭完成签到,获得积分10
2分钟前
CGBIO完成签到,获得积分10
2分钟前
BMG完成签到,获得积分10
2分钟前
朝夕之晖完成签到,获得积分10
2分钟前
嫁个养熊猫的完成签到 ,获得积分10
2分钟前
老迟到的羊完成签到 ,获得积分10
2分钟前
大模型应助科研通管家采纳,获得10
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968521
求助须知:如何正确求助?哪些是违规求助? 3513358
关于积分的说明 11167301
捐赠科研通 3248700
什么是DOI,文献DOI怎么找? 1794453
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804664